United States Personalized Cancer Vaccines Market Trends and Opportunities: Leveraging Biotechnology, AI-Driven Insights, and Targeted Treatment Approaches | Advaxis Inc, BioNtech S E, Celldex Therapeutics

The global personalized cancer vaccines market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.

The Personalized Cancer Vaccines Market focuses on vaccines tailored to individual patients' tumor profiles to stimulate the immune system against cancer cells. These vaccines leverage genomic and proteomic data to provide targeted therapy with minimal side effects. Market growth is driven by advances in immunotherapy, increasing prevalence of cancer, and ongoing clinical research. Hospitals, cancer research centers, and biotechnology firms are primary users. Personalized approaches promise improved efficacy and patient-specific treatment outcomes.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Personalized Cancer Vaccines Market Landscape:- https://datamintelligence.com/download-sample/personalized-cancer-vaccines-market?rk

☛ Personalized Cancer Vaccines Market Recent Developments 2025:

United States: Recent Pharmaceutical Vials Industry Developments

✅ In September 2025, Eli Lilly announced a $5 billion investment in a new drug manufacturing plant in Goochland County, Virginia. The facility will focus on producing active pharmaceutical ingredients for cancer, autoimmune, and advanced therapies, including antibody-drug conjugates.

✅ In September 2025, GSK unveiled plans to invest $30 billion in U.S. manufacturing and research and development over the next five years. This includes a $1.2 billion commitment to build a new manufacturing plant in Pennsylvania and upgrade existing facilities with AI technologies.

✅ In September 2025, Roche announced a $50 billion investment in U.S. manufacturing over the next five years, aiming to mitigate the impact of potential tariffs. The move is expected to generate over 12,000 jobs, including construction roles and positions at expanded and new facilities in Kentucky, New Jersey, California, and other states.

Japan: Recent Pharmaceutical Vials Industry Developments

✅ In September 2025, Japan's pharmaceutical sector is expected to achieve a revenue growth of 7-9% in FY26. This optimistic outlook is largely driven by strong demand in the domestic and European markets.

✅ In September 2025, the Japanese government announced a ¥500 billion ($4.5 billion) investment to support the development and production of pharmaceutical vials and other medical supplies. The initiative aims to strengthen Japan's domestic manufacturing capabilities and reduce reliance on imports.

✅ In September 2025, Japanese pharmaceutical company Takeda announced plans to expand its production facilities for biologic drugs, including the construction of a new vial filling line. The expansion is expected to increase production capacity by 30% and meet growing demand for injectable biologics.

☛ Personalized Cancer Vaccines Market Competitve Landscape:

Genocea Biosciences, Inc., Advaxis Inc, BioNtech S E, Celldex Therapeutics, Bristol-Myers Squibb, Genentech, Gritstone Oncology, Merck & Co, Moderna Therapeutics, Neon Therapeutics.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/personalized-cancer-vaccines-market

☛ Segment Covered in the Personalized Cancer Vaccines Market:

✦ By Cancer Type: Cervical Cancer, Prostate Cancer, Glioblastoma, Others.

✦ By Vaccine Type: Peptide-based Vaccine, Dendritic Cell Vaccine, DNA & RNA Vaccine, Others.

✦ By End-User: Hospitals, Cancer research centers, Clinics, Others.

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Personalized Cancer Vaccines Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=personalized-cancer-vaccines-market

☛ Regional Analysis for Personalized Cancer Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Personalized Cancer Vaccines Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Personalized Cancer Vaccines Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Personalized Cancer Vaccines Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.